SCAMP2 and cancer: Given the importance of Cav3.2 channels in the development of peripheral painful neuropathies [18], it will be interesting to assess to what extent SCAMP2-mediated regulation of Cav3.2 could possibly contribute to cancer-related neuropathic pain.